Lobo A Launer LJ Fratiglioni L Andersen K Di Carlo A Breteler MM Copeland JR Dartigues JF Jagger C Martinez-Lage J Soininen H Hofman A Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group Neurology 2000 54 4-9 
Mendez MF Mendez MA Martin R Smyth KA Whitehouse PJ Complex visual disturbances in Alzheimer&#8217;s disease Neurology 1990 40 439-443 
Holoryd S Sphepherd ML Alzheimer&#8217;s disease: a review for the ophthalmologist Surv Ophthalmol 2001 45 516-524 
Sadun AA Bassi CJ The visual system in Alzheimer&#8217;s disease Res Publ Assoc Res Nerv Ment Dis 1990 67 331-347 
Katz B Rimmer S Ophthalmologic manifestations of Alzheimer&#8217;s disease Surv Ophthalmol 1989 34 31-43 
Pelak VS Hall DA Neuro-ophthalmic manifestations of neurodegenerative disease Ophthalmol Clin North Am 2004 17 311-320 
Fletcher WA Ophthalmological aspects of Alzheimer&#8217;s disease Curr Opin Ophthalmol 1994 5 38-44 
Berisha F Feke GT Trempe CL McMeel JW Schepens CL Retinal abnormalities in early Alzheimer&#8217;s disease Invest Ophthalmol Vis Sci 2007 48 2285-2289 
Hinton DR Sadun AA Blanks JC Miller CA Optic-nerve degeneration in Alzheimer&#8217;s disease N Engl J Med 1986 315 485-487 
Danesh-Meyer HV Birch H Ku JY Carroll S Gamble G Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging Neurology 2006 67 1852-1854 
Syed AB Armstrong RA Smith CU A quantitative analysis of optic nerve axons in elderly control subjects and patients with Alzheimer&#8217;s disease Folia Neuropathol 2005 43 1-6 
Frederikse PH Garland D Zigler JS Jr Piatigorsky J Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells J Biol Chem 1996 271 10169-10174 
Bruban J Glotin AL Dinet V Chalour N Sennlaub F Jonet L An N Faussat AM Mascarelli F Amyloid-beta(1&#8211;42) alters structure and function of retinal pigmented epithelial cells Aging Cell 2009 8 162-177 
Townes-Anderson E Vogt BA Distribution of muscarinic acetylcholine receptors on processes of isolated retinal cells J Comp Neurol 1989 290 369-383 
Katz B Rimmer S Iragui V Katzman R Abnormal pattern electroretinogram in Alzheimer&#8217;s disease: evidence for retinal ganglion cell degeneration? Ann Neurol 1989 26 221-225 
Trick GL Barris MC Bickler-Bluth M Abnormal pattern electroretinogram in patients with senile dementia of the Alzheimer type Ann Neurol 1989 26 226-231 
Parisi V Restuccia R Fattapposta F Mina C Bucci MG Pierelli F Morphological and functional retinal impairment in Alzheimer&#8217;s disease patients Clin Neurophysiol 2001 112 1860-1867 
Partanen J Hartikainen P K&#246;n&#246;nen M Jousm&#228;ki V Soinien H Riekkinen P Prolonged latencies of pattern reversal visual evoked early potentials in Alzheimer disease Alzheimer Dis Assoc Disord 1994 8 250-258 
Pollock VE Schneider LS Chui HC Henderson V Zemansky M Sloane RB Visual evoked potentials in dementia: a meta-analysis and empirical study of Alzheimer&#8217;s disease patients Biol Psychiatry 1989 25 1003-1013 
Grayson AS Weiler EM Sandman DE Visual evoked potentials in early Alzheimer&#8217;s dementia: an exploratory study J Gen Psychol 1995 122 113-129 
Kergoat H Kergoat MJ Justino L Chertkow H Robillard A Bergman H Visual retinocortical function in dementia of the Alzheimer&#8217;s type Gerontology 2002 48 197-203 
Rizzo JF 3rd Cronin-Golomb A Growdon JH Corkin S Rosen TJ Sandberg MA Chiappa KH Lessell S Retinocalcarine function in Alzheimer&#8217;s disease. A clinical and electrophysiological study Arch Neurol 1992 49 93-101 
Strenn K Dal-Bianco P Weghaupt H Koch G Vass C Gottlob I Pattern electroretinogram and luminance electroretinogram in Alzheimer&#8217;s disease J Neural Transm Suppl 1991 33 73-80 
Iseri P Altina&#351; &#214; Tokay T Y&#369;skel N Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease J Neuro-Ophthalmol 2006 26 18-24 
Philpot MP Amin D Levy R Visual evoked potentials in Alzheimer&#8217;s disease: correlation with age and severity Electroencephalogr Clin Neurophysiol 1990 77 323-329 
McKhann G Drachman D Folstein M Katzman R Price D Stadlan EM Clinical Diagnosis of Alzheimer&#8217;s disease: report of the NINCDS-ADRDA work group under the auspices of the department of health and human services task force on Alzheimer&#8217;s disease Neurology 1984 34 939-944 
Folstein MF Folstein SE McHugh PR Mini-mental state. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 1975 12 189-198 
Celesia GG Kaufman D Pattern ERGs and visual evoked potentials in maculopathies and optic nerve diseases Invest Ophthalmol Vis Sci 1985 26 726-735 
Celesia GG Kaufman D Cone SB Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate demyelination from axonal damage to the optic nerve Arch Neurol 1986 43 1247-1252 
Guideline 5: guidelines for standard electrode position nomenclature J Clin Neurophysiol 2006 23 107-110 
Holder GH Heckenlively JR , Arden GB The pattern electroretinogram Principles and practice of clinical electrophysiology of vision 2006 2 Cambridge MIT Press 341-351 
Viswanathan S Frishman LJ Robson JG The uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activity Invest Ophthalmol Vis Sci 2000 41 2797-2810 
Holder GH Heckenlively JR , Arden GB Localizing lesions in the visual system Principles and practice of clinical electrophysiology of vision 2006 2 Cambridge MIT Press 505-517 
Eckstein MB Spalton DJ Holder G Visual loss from central serous retinopathy in systemic lupus erythematosus Br J Ophthalmol 1993 77 607-609 
Lam BL Lam BL Visual evoked potential Electrophysiology of vision. Clinical testing and applications 2005 1 Boca Raton Taylor&amp;Francis Group 123-135 
Bodis-Wollner I Antal A Heckenlively JR , Arden GB Optic nerve and central nervous dysfunctions: Parkinson&#8217;s disease and multiple sclerosis Principles and practice of clinical electrophysiology of vision 2006 2 Cambridge MIT Press 341-351 
Parisi V Pernini C Guinetti C Neuschuler R Bucci MG Electrophysiological assessment of visual pathways in glaucoma Eur J Ophthalmol 1997 7 229-235 
L&#246;ffler KU Edward DP Tso MO Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina Invest Ophthalmol Vis Sci 1995 36 24-31 
Liu B Rasool S Yang Z Glabe CG Schreiber SS Ge J Tan Z Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer&#8217;s transgenic mice Am J Pathol 2009 175 2099-2110 
Melo JB Agostinho P Oliveira CR Amyloid beta-peptide 25&#8211;35 reduces [3H]acetylcholine release in retinal neurons. Involvement of metabolic dysfunction Amyloid 2002 9 221-228 
Aruoma OI Jen SS Watts HR George J Gentleman SM Anderson PJ Jen LS Acute and chronic effects of intravitreally injected beta-amyloid on the neurotransmitter system in the retina Toxicology 2009 256 92-100 
Dimitrieva NA Christianne ES Kent TK Expression of alpha 7 nicotinic acetylcholine receptors by bipolar, amacrine, and ganglion cells of the rabbit retina J Histochem Cytochem 2007 55 461-476 
